PMDA drug package insert
フェキソフェナジン錠「ST」a
PMDA OTC drug · グロー薬品工業（株） · package insert Nov 26, 2024
Key facts
| Brand names | フェキソフェナジン錠「ST」a |
|---|---|
| Companies | 製造販売元／セントラル製薬（株）,販売会社／グロー薬品工業（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | 鼻炎用内服薬 |
| Package insert date | Nov 26, 2024 |
| PMDA document key | 380941_J1801000101 |
| PMDA company code | 380941 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: